Shares of Corbus Pharmaceuticals Holdings Inc. CRBP advanced 1.09% to $1.39 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.50% to 12,582.77 and the Dow Jones Industrial Average DJIA rising 0.35% to 30,173.88. Corbus Pharmaceuticals Holdings Inc. closed $8.39 short of its 52-week high ($9.78), which the company achieved on August 31st.
The stock underperformed when compared to some of its competitors Tuesday, as Fate Therapeutics Inc. FATE rose 9.35% to $91.60, Vanda Pharmaceuticals Inc. VNDA rose 3.02% to $13.65, and Viking Therapeutics Inc. VKTX rose 2.71% to $6.25. Trading volume (3.5 M) remained 1.2 million below its 50-day average volume of 4.7 M.